Equities research analysts at Wedbush issued their Q1 2026 earnings estimates for shares of Telos in a report issued on ...

Fintel reports that on March 14, 2025, Wedbush downgraded their outlook for Sutro Biopharma (NasdaqGM:STRO) from Outperform ...

Arvinas (ARVN) stock faces a downgrade after underwhelming trial data for breast cancer drug vepdegestrant developed with ...

Investment analysts at Wedbush lifted their FY2029 EPS estimates for shares of Apellis Pharmaceuticals in a note issued to ...

Despite the recent sell-off in tech stocks, analysts at Wedbush believe that this downturn is temporary and that AI leaders ...

In-theater advertising company National CineMedia Inc. is well-positioned to reap the benefits of cinema’s unique proposition ...

Wedbush LOS ANGELES, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Wedbush, a Los Angeles-based financial services firm with global reach, and a legacy of innovation and client-focused investment solutions ...

Wedbush Securites, a 70-year-old financial services firm based in Los Angeles, has filed with the Securities and Exchange Commission to enter the ETF space. According to the filing, the proposed ...

Wedbush analysts called Palantir one of their "top names" to own in 2025, expecting the stock to benefit from a "tidal wave of spending on AI." ...

Nvidia ( NASDAQ: NVDA) is set to host its annual GTC conference next week and with tech stocks under pressure from tariffs, concerns of a recession and negative sentiment, Wedbush Securities believes ...